Celularity
Jennifer B. serves as the Executive Director and Head of Financial Planning & Analysis at Celularity Inc. since 2021, leading a corporate FP&A team focused on placental-derived allogeneic cellular therapies in oncology and immunology. Prior experience includes roles at Bristol Myers Squibb and Celgene, where Jennifer managed significant operating budgets, supported research and development initiatives, and directed finance teams across multiple therapeutic areas. Additional roles at Novartis, Sandoz, Johnson & Johnson, sanofi-aventis, and KPMG provided extensive experience in financial leadership, forecasting, and strategic planning within the biopharmaceutical industry. Jennifer holds a Bachelor of Science degree in Accounting from Towson University.
Celularity
3 followers
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics.